Second-line Therapy for Type 2 Diabetes

被引：0
|
作者：
Krome, Susanne
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2024年 / 149卷 / 19期
关键词：
D O I：
10.1055/a-2329-7522
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
About 9% of the world's population is affected by type 2 diabetes. The disease is usually progressive and is associated with multiple complications. If metformin fails to effectively lower HbA1c, additive sulfonylureas, SGLT-2 inhibitors and DPP-4 inhibitors are the most commonly used drugs. Randomized studies have mainly compared their benefits with placebo. Target trial emulation enabled direct comparison.
引用
收藏
页码：1127 / 1128
页数：2
相关论文
共 50 条
  • [1] Type 2 diabetes: second-line antidiabetic therapy in early pregnancy
    Clauss, Maria
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2024, 228 (02): : 119 - 119
  • [2] SGLT-2 inhibitors as second-line therapy in type 2 diabetes
    Tahrani, Abd A.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (09): : 678 - 679
  • [3] Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus
    Shin, Jung-Im
    CURRENT DIABETES REPORTS, 2019, 19 (08)
  • [4] Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus
    Jung-Im Shin
    Current Diabetes Reports, 2019, 19
  • [5] Choosing a second-line therapy after metformin in type 2 diabetes mellitus
    Carol Wilson
    Nature Reviews Endocrinology, 2012, 8 (8) : 441 - 441
  • [6] Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes
    Vashisht, Rohit
    Patel, Ayan
    Dahm, Lisa
    Han, Cora
    Medders, Kathryn E.
    Mowers, Robert
    Byington, Carrie L.
    Koliwad, Suneil K.
    Butte, Atul J.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2336613
  • [7] Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study
    Gottlieb, Assaf
    Yanover, Chen
    Cahan, Amos
    Goldschmidt, Yaara
    BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [8] Glucagon-like Peptide 1 Drugs as Second-line Therapy for Type 2 Diabetes
    Butler, Peter C.
    JAMA INTERNAL MEDICINE, 2016, 176 (10) : 1440 - 1442
  • [9] Quality of Life in People with Type 2 Diabetes following Initiation of Second-Line Therapy: DISCOVER
    Nicolucci, Antonio
    Chen, Hungta
    Cooper, Andrew
    Gomes, Marilia B.
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail N.
    Leigh, Paul
    Ramirez, Larisa
    Shestakova, Marina V.
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Arnold, Suzanne V.
    DIABETES, 2020, 69
  • [10] Glipizide/metformin tablets as second-line therapy in type 2 diabetes: Efficacy, safety, and tolerability
    Rubin, CJ
    Meneghini, L
    Pans, M
    Fiedorek, FT
    DIABETES, 2002, 51 : A113 - A113
12345